Druggio Logo

Druggio

Nihon Medi-Physics

Nihon Medi-Physics is a pharmaceutical company based in Japan. They specialize in the development and manufacturing of radiopharmaceuticals for diagnostic imaging and treatment of various diseases, including cancer and neurological disorders. The company was founded in 1960 and has since focused on the research and production of innovative drugs and medical solutions for the advancement of nuclear medicine.

Nihon Medi-Physics's Drugs

Axumin

Approval date

2021/3/23

Vizamyl

Approval date

2017/9/27

Datscan

Approval date

2013/9/20

Zinc-Tripentat

Approval date

2011/7/1

Ditripentat-Cal

Approval date

2011/7/1

Radiogardase

Approval date

2010/10/27

FDG scan

Approval date

2005/7/25

Benzodine

Approval date

2004/4/23